These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 8761086)

  • 1. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988.
    Hörnsten P; Keisu M; Wiholm BE
    Arch Dermatol; 1990 Jul; 126(7):919-22. PubMed ID: 2360840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dapsone-induced acute pancreatitis.
    Jha SH; Reddy JA; Dave JK
    Ann Pharmacother; 2003 Oct; 37(10):1438-40. PubMed ID: 14519046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agranulocytosis during dapsone administration.
    Ten Broeke JE; Cunningham LD
    Dermatologica; 1973; 146(1):21-4. PubMed ID: 4694139
    [No Abstract]   [Full Text] [Related]  

  • 5. Agranulocytosis--a case report.
    Rahman J; Chowdhury SA; Wajed J
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):65-8. PubMed ID: 11508074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic use of dapsone in dermatitis herpetiformis (Duhring) and in certain inflammatory skin diseases].
    Révész K; Schneider I
    Orv Hetil; 1995 Jan; 136(2):59-62. PubMed ID: 7862431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis.
    Prussick R; Ali MA; Rosenthal D; Guyatt G
    Arch Dermatol; 1992 Feb; 128(2):210-3. PubMed ID: 1739299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferation of IgD kappa plasma cells after agranulocytosis induced by dapsone.
    Lahuerta-Palacios JJ; Gomez-Pedraja JF; Montalban MA; Shandas GJ; Gomez-Salazar MD
    Br Med J (Clin Res Ed); 1985 Jan; 290(6464):282-3. PubMed ID: 3917786
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone-induced peripheral neuropathy. Case report and review.
    Waldinger TP; Siegle RJ; Weber W; Voorhees JJ
    Arch Dermatol; 1984 Mar; 120(3):356-9. PubMed ID: 6322702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dapsone and human polymorphonuclear leucocyte chemotaxis in dermatitis herpetiformis.
    Millar BW; Macdonald KJ; Macleod TM; Raffle EJ
    Acta Derm Venereol; 1984; 64(5):433-6. PubMed ID: 6208726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of sulfones in the treatment of dermatitis herpetiformis with particular reference to adverse effects].
    Pawlik H; Placek W; Kwietniak K
    Przegl Dermatol; 1980; 67(2):221-7. PubMed ID: 6996039
    [No Abstract]   [Full Text] [Related]  

  • 12. A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
    Bhat RM; Radhakrishnan K
    Lepr Rev; 2003 Jun; 74(2):167-70. PubMed ID: 12862258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylator phenotype, minimal maintenance dose and haemolytic effect of dapsone in dermatitis herpetiformis.
    Förström L; Mattila MJ; Mustakallio KK
    Ann Clin Res; 1974 Oct; 6(5):308-10. PubMed ID: 4447343
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention.
    Coleman MD
    Toxicology; 2001 Apr; 162(1):53-60. PubMed ID: 11311458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polyneuropathy in Duhring dermatitis herpetiformis].
    Dillmann U; Krämer G; Goebel HH
    Nervenarzt; 1991 Aug; 62(8):516-8. PubMed ID: 1944718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dapsone for treatment of pruritic dermatitis (dermatitis herpetiformis and subcorneal pustular dermatosis) in dogs.
    Halliwell RE; Schwartzman RM; Ihrke PJ; Goldschmidt MH; Wood MG
    J Am Vet Med Assoc; 1977 Apr; 170(7):697-703. PubMed ID: 858685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone-induced peripheral neuropathy.
    Epstein FW; Bohm M
    Arch Dermatol; 1976 Dec; 112(12):1761-2. PubMed ID: 188385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuing dapsone treatment and reintroducing dietary gluten in patients with dermatitis herpetiformis in remission: comment on "remission in dermatitis herpetiformis".
    Mostow EN
    Arch Dermatol; 2011 Mar; 147(3):305-6. PubMed ID: 21422338
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurologic symptoms posing as dapsone-induced polyneuropathy in two patients with dermatitis herpetiformis.
    Fernandez-Obregon AC; Forconi RJ
    Cutis; 1988 May; 41(5):347-50. PubMed ID: 2836133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dapsone and severe hypoalbuminaemia in dermatitis herpetiformis.
    Cowan RE; Wright JT
    Br J Dermatol; 1981 Feb; 104(2):201-4. PubMed ID: 7213552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.